Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

Reuters

Pfizer starts early-stage trial of combined Covid and flu vaccine

The trial will look at the safety of the combined jab, how effective it is and whether patients suffer any side-effects

The Independent UK

Pfizer trying a jab which protects against flu and Covid

The drug is being tested on 180 people aged 18 to 64

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

New Covid variants are circulating. What do we know and will the Omicron-specific booster be effective?

WHO says the strains are not different enough to label them variants of concern but experts urge staying up to date with vaccines

The Guardian - AU

Dow Drops Over 200 Points; Crude Oil Rises Sharply

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Benzinga

US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views

U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday.

Benzinga

RSV vaccine search could hit third piece of "tripledemic" threat

We've got COVID boosters and flu shots. But there's a missing piece in this triad of tools to cope with what's been dubbed the tripledemic: an RSV vaccine. That could soon change.

Axios

Read news from The Economist, FT, and more,
with one subscription

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

The Independent UK

Covid shots for young kids not popular outside Bangkok

A heavily promoted campaign offering free Covid-19 vaccinations for children is getting a slow response, with parents showing reluctance.

Bangkok Post

These 3 Stocks Are a Must When Building Your Dividend Portfolio

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

Tesla's Autopilot Draws Regulatory Scrutiny, Volkswagen Expects Supply Crisis To Continue, TikTok To Launch Standalone Gaming Channel: Top Stories Friday, Oct. 28

Wall Street Journal Tesla’s Autopilot Draws Regulatory Ire From DoJ and SEC

Benzinga

Shanghai district orders mass COVID-19 testing, lockdown

China's largest city of Shanghai is ordering mass testing on all 1.3 million residents of its downtown Yangpu district and confining them to their homes at least until results are known

The Independent UK

Elon Musk & Philippine Billionaire Come Together For Satellite Internet Service In Southeast Asia, Disney May Track Your Theme Park Preferences, Struggling Credit Suisse Reveals Business Overhaul: Top Stories Thursday, Oct. 27

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Los Angeles Times

'Media literacy' advocates push to create savvier consumers of news and information

The Instagram headline was pithy and alarming: “Head of Pfizer Research: Covid Vaccine is Female Sterilization.” And the report, from a murky source, could have had real-world consequences, coming in 2020, just as the U.S. rolled out the first vaccines to combat the coronavirus pandemic.

Tribune News Service

Lisa Jarvis: What parents can do as RSV spikes among children

A surge in cases of a common respiratory virus is filling up pediatric hospital beds around the U.S. The early and swift arrival of respiratory syncytial virus, or RSV, is stretching the limits of an already exhausted health care system. Layer on COVID and the flu, and you’ve got the…

Benzinga

What Are Whales Doing With Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Irish Mirror

Only a quarter of Irish children got Covid-19 vaccine as HSE gives away 300k doses

Poor uptake in this age group is now likely to significantly add to the stress expected in the health sector over the coming winter months as services struggle to cope with a ‘twindemic’ of flu and Covid

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With PFE

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 20 strange trades.

The Independent UK

Anger as Pfizer reveals Covid shots will cost up to $130 when US government pulls free programme

Pfizer insists most Americans will still be able to access free vaccines, but public health advocates accuse it of “shameless” profiteering

StockNews.com

3 Recession-Proof Stocks to Buy in October

Various headwinds, including the widespread fears of a recession, have kept the market clenched in a bear grip. Amid this backdrop, resilient stocks Pfizer (PFE), Waste Management (WM), and Ingles Markets (IMKTA), which belong to essential sectors and possess inelastic demand for their products or services, could be appropriate additions…

The Independent UK

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots

Axios

Pfizer will start charging $110-$130 a dose for COVID vaccines next year

Price increases, while expected, could lead to higher insurance premiums.

ABC News

Did Pfizer make a 'scandalous' admission to the European Parliament about its COVID-19 vaccine?

Despite a claim that has gone viral, Pfizer never said that pre-market trials of its COVID-19 vaccine tested for its effect on transmission of the virus.

StockNews.com

4 Income Stocks You Could Buy and Hold Forever

As the central banks worldwide are determined to battle sky-high inflation with big rate hikes, top economists warn of a global recession on the way. While volatility is rife in the stock market, reliable dividend-paying stocks Pfizer (PFE), McKesson (MCK), Nutrien (NTR), and Genie Energy (GNE) might be ideal investments…

1 … 33 34 35 36

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.